HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.

Abstract
MicroRNAs (miRNAs) control gene expression by reducing mRNA stability and translation. We aimed to identify alterations in human liver miRNA expression/function in nonalcoholic fatty liver disease (NAFLD). Subjects with the highest (median liver fat 30%, n = 15) and lowest (0%, n = 15) liver fat content were selected from >100 obese patients for miRNA profiling of liver biopsies on microarrays carrying probes for 1438 human miRNAs (a cross-sectional study). Target mRNAs and pathways were predicted for the miRNAs most significantly upregulated in NAFLD, their cell-type-specific expression was investigated by quantitative PCR (qPCR), and the transcriptome of immortalized human hepatocytes (IHH) transfected with the miRNA with the highest number of predicted targets, miR-576-5p, was studied. The screen revealed 42 miRNAs up- and two downregulated in the NAFLD as compared to non-NAFLD liver. The miRNAs differing most significantly between the groups, miR-103a-2*, miR-106b, miR-576-5p, miRPlus-I137*, miR-892a, miR-1282, miR-3663-5p, and miR-3924, were all upregulated in NAFLD liver. Target pathways predicted for these miRNAs included ones involved in cancer, metabolic regulation, insulin signaling, and inflammation. Consistent transcriptome changes were observed in IHH transfected with miR-576-5p, and western analysis revealed a marked reduction of the RAC1 protein belonging to several miR-576-5p target pathways. To conclude, we identified 44 miRNAs differentially expressed in NAFLD versus non-NAFLD liver, 42 of these being novel in the context of NAFLD. The study demonstrates that by applying a novel study set-up and a broad-coverage array platform one can reveal a wealth of previously undiscovered miRNA dysregulation in metabolic disease.
AuthorsJarkko Soronen, Hannele Yki-Järvinen, You Zhou, Sanja Sädevirta, Antti-Pekka Sarin, Marja Leivonen, Ksenia Sevastianova, Julia Perttilä, Pirkka-Pekka Laurila, Alexander Sigruener, Gerd Schmitz, Vesa M Olkkonen
JournalPhysiological reports (Physiol Rep) Vol. 4 Issue 1 (Jan 2016) ISSN: 2051-817X [Print] United States
PMID26733244 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.
Chemical References
  • MicroRNAs
Topics
  • Adult
  • Cell Line, Transformed
  • Cells, Cultured
  • Cross-Sectional Studies
  • Female
  • Hep G2 Cells
  • Hepatocytes (metabolism, pathology)
  • Humans
  • Liver (metabolism, pathology, surgery)
  • Male
  • MicroRNAs (biosynthesis)
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease (metabolism, pathology, surgery)
  • Up-Regulation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: